Join the Syndros group to help and get support from people like you.
Syndros News
Dronabinol Safe, Effective for Alzheimer Disease With Agitation
WEDNESDAY, Oct. 9, 2024 – Dronabinol is safe and effective for the treatment of Alzheimer disease with agitation (Agit-AD), according to a study presented at the annual meeting of the International...
Synthetic THC May Calm Agitation in Alzheimer's Patients
MONDAY, Sept. 30, 2024 – A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows. Synthetic THC (dronabinol) also gave patients'...
FDA Medwatch Alert: The Harvard Drug Group, LLC Issues Voluntary Nationwide Recall of Dronabinol Capsules USP 2.5 mg and Ziprasidone Hydrochloride Capsules 20 mg Due to Label Mix-Up
June 13, 2023 – La Vergne, TN, The Harvard Drug Group, LLC d/b/a Major Pharmaceutical and Rugby Laboratories is initiating a voluntary recall of a single lot of Dronabinol Capsules, USP, 2.5 mg and Z...
Insys Therapeutics Announces FDA Approval of Syndros (dronabinol) Oral Solution
PHOENIX, July 05, 2016 (GLOBE NEWSWIRE) – Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY) today announced that the U.S. Food and Drug Administration (FDA) has approved Insys’ dronab...
Further information
Related condition support groups
Nausea / Vomiting - Chemotherapy Induced